Best Life Sciences Companies in Community of Madrid, Spain

Biohope develops assay solutions for the management of organ rejection in kidney transplant patients. Its flagship product is a 3D-cell culture that enables physicians to tailor immunosuppressants for renal transplant patients. This assay can be used to prescribe a treatment regimen that prevents organ rejection, and adverse immune reactions due to overuse of immunosuppressants.

Funding rounds

• May 2026Seed—
• Jun 2019Grant (prize money)$4.4M
• Jan 2017Grant (prize money)$4M
• Jun 2016Grant (prize money)—

Founders & team

Isabel PorteroFounder & CEO

Investors

EIC Fund, Europa, Kidney, Dreavent

Tech stack

Apache Http ServerBootstrapContact Form 7CookieyesGoogle AnalyticsGoogle Tag Manager

Developer of clear aligner orthodontic system integrating archwire and 3D-printed components. The system combines archwire force with aligner invisibility. It uses 3D-designed and custom-made components. The system includes individually sectioned copings for controlled movement. Brackets direct movement by flexing the archwire. Attachments secure the coping to the tooth. Encapsulation protects the archwire for comfort.

Provider of diagnostic tools to support personalized cancer treatment. The company has developed prognostic, diagnostic, and predictive tests for lung cancer, colorectal cancer, and prostate cancer. Its colon cancer test ColoFast is a blood-based miRNA test for early detection of colon cancer. It is also developing DiagnoLung which is a blood-based ELISA test that measures the level of three protein biomarkers to screen high-risk patients for non-small-cell lung cancer.

Funding rounds

• Feb 2025Venture Debt$15.6M
• Aug 2022Grant (prize money)$2.6M
• Jun 2021Grant (prize money)$3.4M
• Oct 2020Grant (prize money)$152.1K

Founders & team

Rocio ArroyoCEO

Investors

Europa, CRB Inverbio, Inveready, Alentia, EIC Fund, European Investment Bank

Tech stack

Anime.JsApache Http ServerAstraCloudflareContact Form 7Cookieyes

Developer of nutritional supplements to enhance overall health and well-being. The company's products, including be calm, triple magnesium, and creatine, are backed by scientific research and aim to promote relaxation, reduce anxiety, and enhance physical performance.

MedLumics is a developer of biological tissue imaging by using optical coherence tomography. It is using infrared light this imaging modality allows for noninvasively, sectional images of the inside of biological tissues with micrometer resolution. This is also known as a virtual biopsy. The technology platform MedLumics OCT is a point of care optical imaging solution for diagnosis. According to the company, it can also find application in the management of skin diseases. Its product, Nitid, a product for diagnostic imaging for the management of skin problems. The device weighs around 3kg is sold under CE by DermaLumics, a sister company focused on the dermatology market.

MedicSen offers a mobile application that can monitor and predict future glucose levels and recommends meals, insulin doses and exercise to manage diabetes. The application can also automatically collect data from connected glucometers. The company is also developing Smart-patch for the administration of insulin without needles, that will take information from the App to personalize the treatment automatically according to the needs of the patient.

Developer of tool for monitoring and studying alive single cell. The SPAchip Technology is used to study alive cell behavior, physiology, and information of cells. It is also used to analyze interactions among biomolecules and monitor individual cell responses over time.

Funding rounds

• Nov 2023Series B$3.3M
• Apr 2022Grant (prize money)$747.2K
• Dec 2021Series A$1.4M
• Apr 2019Seed$728.7K

Founders & team

Elena RivasCEO

Investors

BeAble Capital, Innvierte Economia Sostenible Sicc Sme, Ideas de bomberossl, Dreavent, Europa

Cellerix engages in the development and production of medicines based on the use of stem cells of adult origin. The company offers products for the treatment of gastroenterology, dermatology, and immune-based diseases. Its products include Cx401, which is used for the treatment of complex perianal fistulas; and Cx501, a cell therapy product to be applied in the treatment of Epidermolysis Bullosa.

Developer of robotic exoskeleton for children's mobility. It has developed lower body exoskeleton gear ranging from a single joint to full active orthosis from trunk to foot. The bionics feature controllable stiffness and this helps in personalizing therapy progress. The products are aimed at patients with neuromuscular diseases, spinal cord injuries, and more.

Veritas provides genomic services. The company provides genetic testing and genetic counseling services. The company offers a range of genomic testing services for health, newborn hereditary disease risk, cancer diagnosis, pharmacogenetics, and others.

Funding rounds

• Sep 2020Series B$5.9M

Founders & team

George ChurchFounderJavier EchevarriaCEO

Investors

Amadeus Capital, Charme Capital Partners, Stemar Capital, GSP Capital

Tech stack

Amazon Web ServicesAnimate.CssCloudflareCloudflare Bot ManagementContact Form 7Facebook Pixel

Developer of recombinant biologics for animal and human health. It has developed platforms within a baculovirus expression vector system that includes Top-Bac, a proprietary expression cassette which helps to improve the quality of proteins produced and IBES which is based on the use of insect larvae as disposable, living bioreactors. It claims that the proteins produced can be used to develop vaccines, diagnostic reagents, and therapeutic molecules.

Smart device for checking insulin adherence